A failed clinical trial for Zynerba Pharmaceuticals Inc.'s cannabidiol gel in adult epilepsy sent its stock plummeting 58.5% in heavy morning trade ...

Cannabidiol (Epidiolex) may alter blood levels of several commonly used antiepileptic drugs in adults and children, according to an open-label study ...

The products are made from cannabidiol, or CBD, which is oil extracted from industrial hemp, a variety of the cannabis plant with a low concentration ...

Cbdrus, which is to sell cannabidiol as a food supplement, is expected to launch in Burnley tomorrow. It has been trading over the internet for about 18 ...

According to that source, the situation is only limited to CBD (Cannabidiol) isolates, so exporting CBD Oil under the label of “Hemp Oil” might still work, ...

Jacob, A., and A. R. Todd. “119. Cannabis indica. Part II. Isolation of cannabidiolfrom Egyptian hashish. Observations on the structure of cannabinol.

Enrollment is complete in its Phase 2 STOP (Synthetic Transdermal Cannabidiol for Treatment of Knee Pain due to Osteoarthritis) study in patients ...

The drugs that have been approved to date are synthetic forms of cannabidiol (CBD) and tetrahydrocannabinol (THC). THC is the major psychoactive ...

The health benefits of cannabidiol (CBD), the non-psychoactive composite in cannabis, isn't necessarily news, But this particular point is: according to ...

The title of the presentation is: "Analogue Derivatization Of Cannabidiol (CBD) For Improved Ocular Permeation: In Vitro And In Vivo Evaluation.".

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) fell $8.39 (56%) to $6.67 on Mondayafter reporting that its synthetic cannabidiol (CBD) gel ZYN002 ...

Aim: To assess the feasibility of the use of cannabidiol (CBD) for the management of cannabis withdrawal. Patients & methods: Eight participants were ...

*GW Pharma shares surge 2.7% after Zynerba Pharma's failed cannabidiol gel trial. BY MarketWatch — 9:38 AM ET 08/07/2017. (END) Dow Jones ...